by Elvis Guaman | Jun 24, 2025 | Biotechnology, Market News, Medical Use, Pharmaceutical, Stock Market
Nektar Therapeutics (NKTR) saw its stock surge 86% Tuesday morning after reporting strong midstage trial results for its experimental eczema treatment, rezpegaldesleukin. Shares opened at a seven-month high, after initially showing a triple-digit gain in premarket...
